학술논문

Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists.
Document Type
Article
Source
Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders. Dec2000 Supplement 4, Vol. 1, p45-54. 10p.
Subject
*AMYOTROPHIC lateral sclerosis treatment
*ADRENERGIC beta agonists
Language
ISSN
1466-0822
Abstract
Explores strategies to develop mosaic chemotherapeutic approaches for amyotrophic lateral sclerosis/motor neurone disease (ALS/MND). Inclusion of beta-2 adrenergic agonists for ALS/MND treatment; Pathogenesis-based and symptom-directed therapies in ALS/MND; Effect of beta-2 adrenergic agonists in the central nervous system and muscular system; Side-effects of beta-2 adrenergic agonists.